Announcements Trials
Browse Landscape

Phase

Phase 2 92Phase 3 40Phase 1 36Phase 1/2 16Phase NA 12Phase 2/3 7Phase EARLY_PHASE1 2Phase 4 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 15Other hematologic neoplasm 10Breast 3Sarcoma 2Plasma cell 2Genitourinary 2Gastrointestinal 2Other 1Dermatologic 1

Conditions

Sarcoma 1Rhabdomyosarcoma 1

Interventions

Imatinib Mesylate 3nilotinib 2Sunitinib 2Ibandronic Acid 2Doxorubicin 2Cyclophosphamide 2regorafenib 1pegylated granulocyte colony-stimulating factor 1nirogacestat 1avapritinib 1anlotinib 1Zoledronic Acid 1Tranexamic Acid 1Thiotepa 1Ritonavir 1Radiotherapy 1Pregabalin 1Oxaliplatin 1Nevirapine 1Midazolam 1Lopinavir 1Lithium Carbonate 1Lead 1Kyphoplasty 1Indocyanine Green 1Ifosfamide 1Hyperbaric Oxygenation 1Filgrastim 1Esomeprazole 1Erlotinib Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Doxorubicin × Sarcoma × Clear all
NCT03514381 2026-04-14

IPIAP-STM

Institut Claudius Regaud

Phase 4 Completed
59 enrolled
Sarcoma

Sarcoma

NCT00339118 2006-06-20

EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children

Sheba Medical Center

Phase 4 Unknown
Sarcoma

Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡